Literature DB >> 20455257

Ectopic expression of the microtubule-dependent motor protein Eg5 promotes pancreatic tumourigenesis.

Min Liu1, Xiuchao Wang, Yunfan Yang, Dengwen Li, He Ren, Qigang Zhu, Qiang Chen, Shuyong Han, Jihui Hao, Jun Zhou.   

Abstract

Pancreatic cancer is a highly aggressive disease with a grim prognosis, due to its late diagnosis, propensity to rapidly metastasize, and resistance to therapy. The molecular events underlying this remain poorly defined. Here we report the overexpression and gene copy number gain of the microtubule-dependent motor protein Eg5 in human pancreatic cancer samples. We also show that Eg5 expression correlates with clinicopathological parameters of pancreatic cancer and promotes anchorage-independent cell growth and tumour formation in mice. In addition, Eg5 is up-regulated in pancreatic cancer cell lines and enhances cell proliferation in an ATPase activity-dependent manner. Our data further reveal that Eg5 overexpression causes the formation of multipolar spindles and multinucleation and induces the accumulation of polyploid cells. These findings demonstrate a role for Eg5 in pancreatic tumourigenesis and indicate a potential for targeting Eg5 in pancreatic cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20455257     DOI: 10.1002/path.2706

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  41 in total

Review 1.  Illicit survival of cancer cells during polyploidization and depolyploidization.

Authors:  I Vitale; L Galluzzi; L Senovilla; A Criollo; M Jemaà; M Castedo; G Kroemer
Journal:  Cell Death Differ       Date:  2010-11-12       Impact factor: 15.828

2.  P190RhoGAP prevents mitotic spindle fragmentation and is required to activate Aurora A kinase at acentriolar poles.

Authors:  Arkadi Manukyan; Lilit Sargsyan; Sarah J Parsons; P Todd Stukenberg
Journal:  Chromosoma       Date:  2018-04-14       Impact factor: 4.316

3.  Synergism between inhibitors of Aurora A and KIF11 overcomes KIF15-dependent drug resistance.

Authors:  Hoi Tang Ma; Sergio Erdal; Shan Huang; Randy Y C Poon
Journal:  Mol Oncol       Date:  2014-06-02       Impact factor: 6.603

4.  Dimethylenastron suppresses human pancreatic cancer cell migration and invasion in vitro via allosteric inhibition of mitotic kinesin Eg5.

Authors:  Xiao-dong Sun; Xing-juan Shi; Xiao-ou Sun; You-guang Luo; Xiao-jing Wu; Chang-fu Yao; Hai-yang Yu; Deng-wen Li; Min Liu; Jun Zhou
Journal:  Acta Pharmacol Sin       Date:  2011-10-10       Impact factor: 6.150

Review 5.  A New Way to Treat Brain Tumors: Targeting Proteins Coded by Microcephaly Genes?: Brain tumors and microcephaly arise from opposing derangements regulating progenitor growth. Drivers of microcephaly could be attractive brain tumor targets.

Authors:  Patrick Y Lang; Timothy R Gershon
Journal:  Bioessays       Date:  2018-03-26       Impact factor: 4.345

Review 6.  Kinesins and cancer.

Authors:  Oliver Rath; Frank Kozielski
Journal:  Nat Rev Cancer       Date:  2012-07-24       Impact factor: 60.716

7.  Regulation of tumor angiogenesis by the microtubule-binding protein CLIP-170.

Authors:  Xiaodong Sun; Fang Li; Bin Dong; Shaojun Suo; Min Liu; Dengwen Li; Jun Zhou
Journal:  Protein Cell       Date:  2013-04-03       Impact factor: 14.870

8.  Validation of Polo-like kinase 1 as a therapeutic target in pancreatic cancer cells.

Authors:  Chao Zhang; Xiaodong Sun; Yuan Ren; Yunbo Lou; Jun Zhou; Min Liu; Dengwen Li
Journal:  Cancer Biol Ther       Date:  2012-08-15       Impact factor: 4.742

9.  Parkin deficiency contributes to pancreatic tumorigenesis by inducing spindle multipolarity and misorientation.

Authors:  Xiaodong Sun; Min Liu; Jihui Hao; Dengwen Li; Youguang Luo; Xiuchao Wang; Yunfan Yang; Fang Li; Wenqing Shui; Quan Chen; Jun Zhou
Journal:  Cell Cycle       Date:  2013-03-07       Impact factor: 4.534

10.  The expression of Eg5 predicts a poor outcome for patients with renal cell carcinoma.

Authors:  Dingqi Sun; Jiaju Lu; Kejia Ding; Dongbin Bi; Zhihong Niu; Qingwei Cao; Jie Zhang; Sentai Ding
Journal:  Med Oncol       Date:  2013-02-01       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.